Home/Filings/4/0000950170-24-084346
4//SEC Filing

Knight Jeff E. 4

Accession 0000950170-24-084346

CIK 0001658247other

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 5:35 PM ET

Size

15.8 KB

Accession

0000950170-24-084346

Insider Transaction Report

Form 4
Period: 2024-07-15
Knight Jeff E.
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Stock option (Right to Buy)

    2024-07-1517,499112,501 total
    Exercise: $23.98Exp: 2031-09-01Common Stock (17,499 underlying)
  • Exercise/Conversion

    Common Stock

    2024-07-15$23.98/sh+17,499$419,62670,079 total
  • Exercise/Conversion

    Stock option (Right to Buy)

    2024-07-152,88720,213 total
    Exercise: $20.02Exp: 2032-02-29Common Stock (2,887 underlying)
  • Exercise/Conversion

    Stock option (Right to Buy)

    2024-07-155,68785,313 total
    Exercise: $19.64Exp: 2033-03-01Common Stock (5,687 underlying)
  • Exercise/Conversion

    Common Stock

    2024-07-15$19.64/sh+5,687$111,69378,653 total
  • Sale

    Common Stock

    2024-07-15$55.00/sh27,000$1,485,00051,653 total
  • Exercise/Conversion

    Common Stock

    2024-07-15$20.02/sh+2,887$57,79872,966 total
Footnotes (4)
  • [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The option is exercisable as follows: 25% of the shares subject to the option vest on August 30, 2022, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
  • [F3]1/48th of the shares subject to the option vested on March 31, 2022, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
  • [F4]1/48th of the shares subject to the option vested on April 1, 2023, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Documents

1 file

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1
  • filerCIK 0001881007

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:35 PM ET
Size
15.8 KB